Publications
223
Citations
1,318
Est. group size
~10
Recurring co-author estimate
Active years
24
Publishing since 2002
Steven T. Sizemore's research focuses on breast cancer, particularly the biological mechanisms that allow cancer cells to spread (metastasize) to other parts of the body. His work examines specific genes and proteins, such as BCL11A, RALA/RALB, and follistatin, that influence tumor progression and how existing or experimental drugs might be combined to treat aggressive subtypes like triple-negative and HER2-positive breast cancer.
Publication output was modest and fairly steady from 2017-2022, then showed a large spike in 2023 followed by a drop and partial rebound, suggesting an unusual and irregular recent pattern rather than steady growth.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID–Next-Generation Sequencing in North Carolina
UNC Libraries · 2023
- The RAL Enigma: Distinct Roles of RALA and RALB in Cancer
Cells · 2022
- The transcriptional repressor BCL11A promotes breast cancer metastasis
Journal of Biological Chemistry · 2020
- Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Journal of Visualized Experiments · 2020
- Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment
Oncotarget · 2020
- Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Journal of Visualized Experiments · 2020
- Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
Breast Cancer Research · 2017
- Additional file 1: of Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
Figshare · 2017
- Additional file 1: of Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
Figshare · 2017
- Cancer Research×18
- Breast Cancer Research×3
- Neuro-Oncology Advances×3
- Clinical Cancer Research×3
- Journal of Visualized Experiments×2
- Gina M. Sizemore
Medicine · The Ohio State University
- Hélène Le Pommellet
Medicine · The Ohio State University
- Briana To
Medicine · The Ohio State University
- Amanda J. Saraf
Medicine · Indiana University
- Ananya Banerjee
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile